{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:21:21Z","timestamp":1788891681284,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T00:00:00Z","timestamp":1606089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"inistry of Health of Brazil"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ijid.2020.11.183","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T11:46:14Z","timestamp":1606477574000},"page":"358-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial"],"prefix":"10.1016","volume":"103","author":[{"given":"Luciana","family":"Mendes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Oliveira","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bleno","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ar\u00edneia Soares da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria das Gra\u00e7as Barbosa","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Smith","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Villarouco da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denison Vital","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel","family":"Barral-Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerson","family":"Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar M.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo R.L.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijid.2020.11.183_bib0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4269\/ajtmh.2005.73.79","article-title":"Successful treatment of refractory cutaneous leishmaniasis with GM-CSF and antimonials","volume":"73","author":"Almeida","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ijid.2020.11.183_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.2007.77.266","article-title":"Treatment of mucosal leishmaniasis in Latin America: Systematic review","volume":"77","author":"Amato","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.ijid.2020.11.183_bib0015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4067\/S0716-10182013000600020","article-title":"Leishmaniasis cut\u00e1nea y herpes zoster multidermat\u00f3mico [Cutaneous leishmaniasis and multidermatomic herpes zoster]","volume":"30","author":"Arboleda","year":"2013","journal-title":"Rev Chilena Infectol"},{"issue":"3","key":"10.1016\/j.ijid.2020.11.183_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.inhe.2012.06.004","article-title":"Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis","volume":"4","author":"Blum","year":"2012","journal-title":"Int Health"},{"issue":"1","key":"10.1016\/j.ijid.2020.11.183_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-018-2743-6","article-title":"Composition of sand fly fauna (Diptera: Psychodidae) and detection of Leishmania DNA (Kinetoplastida: Trypanosomatidae) in different ecotopes from a rural settlement in the central Amazon, Brazil","volume":"11","author":"Chagas","year":"2018","journal-title":"Parasites Vectors"},{"issue":"2","key":"10.1016\/j.ijid.2020.11.183_bib0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4269\/ajtmh.2011.10-0155","article-title":"Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania (Viannia) guyanensis in Manaus, Brazil","volume":"84","author":"Chrusciak-Talhari","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"December 2013","key":"10.1016\/j.ijid.2020.11.183_bib0035","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/0037-8682-0268-2013","article-title":"Tegumentary leishmaniasis in the state of amazonas: What have we learned and what do we need?","volume":"48","author":"De Guerra","year":"2015","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"10.1016\/j.ijid.2020.11.183_bib0040","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1590\/abd1806-4841.20153956","article-title":"Efficacy and safety of a single dose pentamidine (7mg\/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study","volume":"90","author":"Gadelha","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"10","key":"10.1016\/j.ijid.2020.11.183_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006850","article-title":"An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of cutaneous leishmaniasis in the Amazon Region","volume":"12","author":"Gadelha","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"24","key":"10.1016\/j.ijid.2020.11.183_bib0050","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian viceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N Engl J Med"},{"issue":"8397","key":"10.1016\/j.ijid.2020.11.183_bib0055","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(84)90346-5","article-title":"Possible risk factors in development of mucosal lesions in leishmaniasis","volume":"2","author":"Llanos-Cuentas","year":"1984","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijid.2020.11.183_bib0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/AAC.01415-06","article-title":"Miltefosine (hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigotes","volume":"51","author":"Luque-Ortega","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.ijid.2020.11.183_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000912","article-title":"Miltefosine in the treatment of cutaneous leishmaniasis caused by leishmania braziliensis in Brazil: A randomized and controlled trial","volume":"4","author":"Machado","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.ijid.2020.11.183_bib0070","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4269\/ajtmh.2009.80.339","article-title":"Leishmania (Viannia) guyanensis induces low immunologic responsiveness in leishmaniasis patients from an endemic area of the Brazilian Amazon highland","volume":"80","author":"Matta","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.ijid.2020.11.183_bib0075","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1590\/S0365-05962011000600005","article-title":"Estudo cl\u00ednico randomizado comparando antimoniato de meglumina, pentamidina e anfotericina B para o tratamento da leishmaniose cut\u00e2nea ocasionada por Leishmania guyanensis","volume":"86","author":"Neves","year":"2011","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.ijid.2020.11.183_bib0080","article-title":"Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis","volume":"6","author":"Peixoto","year":"2020","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ijid.2020.11.183_bib0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cid\/ciw662","article-title":"Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial","volume":"64","author":"Prates","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.11.183_bib0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.intimp.2012.03.016","article-title":"Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL\/6 mice","volume":"13","author":"Ponte","year":"2012","journal-title":"Int Immunopharmacol [Internet]"},{"issue":"4","key":"10.1016\/j.ijid.2020.11.183_bib0095","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/AAC.01123-06","article-title":"Miltefosine affects lipid metabolism in Leishmania donovani promastigotes","volume":"51","author":"Rakotomanga","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.ijid.2020.11.183_bib0100","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/319990","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: Clinical findings and diagnostic approach","volume":"32","author":"Romero","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2020.11.183_bib0105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2230.2007.02405.x","article-title":"Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate","volume":"32","author":"Sadeghian","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.ijid.2020.11.183_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178592","article-title":"Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil","volume":"12","author":"Saheki","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2020.11.183_bib0115","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1086\/424848","article-title":"Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study","volume":"190","author":"Santos","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2020.11.183_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijbiomac.2009.04.005","article-title":"Molecular cloning, expression in Escherichia coli and production of bioactive homogeneous recombinant human granulocyte and macrophage colony stimulating factor","volume":"45","author":"Schwanke","year":"2009","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"10.1016\/j.ijid.2020.11.183_bib0125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/sj.cr.7310017","article-title":"Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: What we do and don\u2019t know","volume":"16","author":"Shi","year":"2006","journal-title":"Cell Res"},{"key":"10.1016\/j.ijid.2020.11.183_bib0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4269\/ajtmh.19-0531","article-title":"Clinical Presentation and Response to Therapy in Children with Cutaneous Leishmaniasis","volume":"102","author":"Suprien","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"11","key":"10.1016\/j.ijid.2020.11.183_bib0135","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Saha B. Miltefosine Promotes IFN-\u03b3-Dominated Anti-Leishmanial Immune Response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2020.11.183_bib0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1086\/514689","article-title":"Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis","volume":"27","author":"Wortmann","year":"1998","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220324966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220324966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:58:50Z","timestamp":1761119930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220324966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":28,"alternative-id":["S1201971220324966"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.11.183","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.11.183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}